These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 8575469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.
    Kostakoglu L, Uysal U, Ozyar E, Elahi N, Hayran M, Uzal D, Demirkazik FB, Kars A, Uğur O, Atahan L, Bekdik CF.
    J Nucl Med; 1996 Dec; 37(12):1956-62. PubMed ID: 8970513
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
    Dancheva Z, Bochev P, Chaushev B, Yordanova T, Klisarova A.
    Nucl Med Rev Cent East Eur; 2016 Dec; 19(1):22-7. PubMed ID: 26841376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative value of thallium and glucose SPECT imaging in childhood brain tumors.
    Maria BL, Drane WE, Mastin ST, Jimenez LA.
    Pediatr Neurol; 1998 Nov; 19(5):351-7. PubMed ID: 9880139
    [Abstract] [Full Text] [Related]

  • 10. Comparison between 201Tl-chloride and 99Tc(m)-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients.
    Naddaf SY, Akisik MF, Aziz M, Omar WS, Hirschfeld A, Masdeu J, Donnenfeld H, Abdel-Dayem HM.
    Nucl Med Commun; 1998 Jan; 19(1):47-53. PubMed ID: 9515546
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y, Kikuchi T, Kajihara M, Semba T, Ochi T, Fujii T, Mochizuki T, Sakayama K, Nakata S.
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
    Sato O, Kawai A, Ozaki T, Kunisada T, Danura T, Inoue H.
    J Orthop Sci; 1998 Sep; 3(6):297-303. PubMed ID: 9811980
    [Abstract] [Full Text] [Related]

  • 16. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group.
    Panicek DM, Gatsonis C, Rosenthal DI, Seeger LL, Huvos AG, Moore SG, Caudry DJ, Palmer WE, McNeil BJ.
    Radiology; 1997 Jan; 202(1):237-46. PubMed ID: 8988217
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
    Goto Y, Ihara K, Kawauchi S, Ohi R, Sasaki K, Kawai S.
    J Orthop Sci; 2002 Jan; 7(3):304-12. PubMed ID: 12077654
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of 201Tl SPECT and CT in the follow-up of irradiated brain tumors.
    Datta NR, Pasricha R, Gambhir S, Prasad SN, Phadke RV.
    Int J Clin Oncol; 2004 Feb; 9(1):51-8. PubMed ID: 15162827
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.